ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,970Medicare Part D Prescriptions Filled, Including Refills

Rank: 7 out of 97

$790K Total Retail Price of All Prescriptions

Rank: 14 out of 97

490 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
38% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Dakota
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 490 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

5% of this provider’s 490 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

1% of this provider’s 16,250 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

37 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Dakota
LEVOTHYROXINE SODIUM 1,189 1,092 1 1
LISINOPRIL 946 855 2 4
FUROSEMIDE 874 809 3 3
OMEPRAZOLE 751 606 4 5
SIMVASTATIN 659 565 5 2
POTASSIUM CHLORIDE 654 603 6 10
AMLODIPINE BESYLATE 634 621 7 6
HYDROCHLOROTHIAZIDE 490 466 8 9
SERTRALINE HCL 471 439 9 16
METOPROLOL TARTRATE 390 352 10 7
WARFARIN SODIUM 347 347 11 11
ISOSORBIDE MONONITRATE ER 334 334 12 27
METOPROLOL SUCCINATE 303 271 13 8
ATENOLOL 293 272 14 15
LOSARTAN POTASSIUM 283 271 15 13
ALENDRONATE SODIUM 266 266 16 19
LANTUS SOLOSTAR 266 238 16 41
DOXAZOSIN MESYLATE 253 253 18 45
KLOR-CON 10 203 158 19 65
METFORMIN HCL 199 184 20 12
DONEPEZIL HCL 181 170 21 24
CARVEDILOL 178 166 22 25
GLIPIZIDE XL 176 150 23 86
CRESTOR 153 134 24 29
DIGOXIN 144 144 25 26
ATORVASTATIN CALCIUM 142 133 26 14
DILTIAZEM ER 135 135 27 85
NAMENDA 131 119 28 38
ALLOPURINOL 129 123 29 22
PREDNISONE 128 119 30 23
FENTANYL 121 120 S2 31 50
GABAPENTIN 120 98 32 18
LANTUS 119 83 33 43
GLIPIZIDE ER 118 99 34 111
CLOPIDOGREL 117 114 35 34
ADVAIR DISKUS 115 104 36 40
FAMOTIDINE 115 90 36 105
PRAMIPEXOLE DIHYDROCHLORIDE 109 109 38 136
LISINOPRIL-HYDROCHLOROTHIAZIDE 108 104 39 36
ZOLPIDEM TARTRATE 106 105 40 32
JANTOVEN 103 102 41 37
DILTIAZEM 24HR ER 94 94 42 69
PEN NEEDLE 94 88 42 57
NABUMETONE 93 78 44 178
GLIPIZIDE 91 77 45 78
SPIRONOLACTONE 86 86 46 33
FLUOXETINE HCL 85 78 47 63
PROPRANOLOL HCL 85 68 47 83
JANUVIA 84 72 49 59
LYRICA 82 74 50 100
DILTIAZEM 24HR CD 81 81 51 73
PLAVIX 77 75 52 46
CITALOPRAM HBR 76 76 53 20
BENAZEPRIL HCL 76 64 53 109
KLOR-CON M20 73 66 55 92
TRAMADOL HCL 71 67 56 21
RANITIDINE HCL 70 65 57 67
PRAVASTATIN SODIUM 70 69 57 28
LEVOFLOXACIN 69 64 59 101
ESCITALOPRAM OXALATE 69 52 59 93
FLOVENT HFA 64 57 61 199
NOVOLOG FLEXPEN 61 51 62 74
POLYETHYLENE GLYCOL 3350 59 30 63 55
NOVOLOG 57 41 64 123
LOSARTAN-HYDROCHLOROTHIAZIDE 55 50 65 49
OXYCODONE-ACETAMINOPHEN 53 51 S2 66 117
RAMIPRIL 50 50 67 68
TRIAMTERENE-HCTZ 50 40 67 30
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.